Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 18 de 18 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Outbreak Alert: Potential life-threatening vitamin K-dependent antagonist coagulopathy associated with synthetic cannabinoids use. Centers for Disease Control and Prevention 2018:5 de abril. [Ref.ID 102503]
2.Tiene citas relacionadas Cita con resumen
Williams D, Gutiérrez JM, Harrison R, Warrell DA, White J, Winkel KD, Gopalakrishnakone P, on behalf of the Global Snake Bite Initiative Working Group and International Society on Toxinology. The Global Snake Bite Initiative: an antidote for snake bite. Lancet 2010;375:89-91. [Ref.ID 87536]
3.Tiene citas relacionadas Cita con resumen
Warrell DA. Snake bite. Lancet 2010;375:77-88. [Ref.ID 87535]
4. Cita con resumen
Stumpf JL, Shehab N, Patel AC. Safety of angiotensin-converting enzyme inhibitors in patients with insect venom allergies. Ann Pharmacother 2006;40:699-703. [Ref.ID 76796]
5.
Smalligan R, Cole J, Brito N, Laing GD, Mertz BL, Manock S, Maudlin J, Quist B, Holland G, Nelson S, Lalloo DG, Rivadeneira G, Barragan ME, Dolley D, Eddleston M, Warrell DA, Theakston RDG. Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms. BMJ 2004;329:1129-33. [Ref.ID 71883]
6. Cita con resumen
Griffin JP. Venetian treacle and the foundation of medicines regulation. Br J Clin Pharmacol 2004;58:317-25. [Ref.ID 71380]
7. Cita con resumen
The International Collaborative Study of Severe Anaphylaxis. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003;12:195-202. [Ref.ID 65884]
8. Cita con resumen
Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med 2002;347:347-56. [Ref.ID 62905]
9.
Dobson R. Spider venom may prevent atrial fibrillation. BMJ 2001;322:71. [Ref.ID 57054]
10.Tiene citas relacionadas
Sherman DG, Levy DE. Outcomes of ancrod in acute ischemic stroke. In reply. JAMA 2000;284:1927. [Ref.ID 53565]
11.Tiene citas relacionadas
Orgogozo JM, Verstraete M, Kay R, Hennerici M, Lenzi G-L. Outcomes of ancrod in acute ischemic stroke. JAMA 2000;284:1926-7. [Ref.ID 53564]
12.Tiene citas relacionadas
Orbach D, Levine D. Outcomes of ancrod in acute ischemic stroke. JAMA 2000;284:1926. [Ref.ID 53563]
13.Tiene citas relacionadas
Mayberg MR, Furlan A. Ancrod - is snake venom and antidote for stroke?. JAMA 2000;283:2440-2. [Ref.ID 50867]
14.Tiene citas relacionadas Cita con resumen
Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, Hsu CY, Levy DE, for the STAT Participants. Intravenous ancrod for treatment of acute ischemic stroke. The STAT Study: a randomized controlled trial. JAMA 2000;283:2395-403. [Ref.ID 50858]
15.
Heard K, O'Malley GF, Dart RC. Antivenom therapy in the Americas. Drugs 1999;58:5-15. [Ref.ID 45221]
16. Cita con resumen
Collinson HL, Wheeler DC. Drug-induced rhabdomyolysis. Adv Drug React Bull 1999;196:747-50. [Ref.ID 44864]
17. Cita con resumen
Senior K. Taking the bite out of snake venoms. Lancet 1999;353:1946. [Ref.ID 44847]
18.
Ewan PW. Venom allergy. BMJ 1998;316:1365-8. [Ref.ID 39546]
Seleccionar todas
 
 1 a 18 de 18